Home » Authors » James Etheridge

Articles by James Etheridge

Nautilus Biotech Gets EUR7.25M In Third Round Of Financing

April 6, 2005

By James Etheridge

Flamel Technologies Terminates Licensing Agreement for Genvir

March 9, 2005

By James Etheridge

Flamel Technologies Terminates Licensing Agreement for Genvir

March 9, 2005

By James Etheridge

International report: Institutions claim victory in BRCA1 gene patent battle

Feb. 24, 2005

By James Etheridge

Report from Europe: Institutions claim victory in BRCA1 gene patent battle

Feb. 16, 2005

By James Etheridge

Europeans Claim Victory In BRCA1 Gene Patent Battle

Feb. 9, 2005

By James Etheridge

Gene Therapy Study In France Halted After Third Complication

Feb. 9, 2005

By James Etheridge

Gene Therapy Study In France Halted After Third Complication

Feb. 9, 2005

By James Etheridge

Europeans Claim Victory In BRCA1 Gene Patent Battle

Feb. 9, 2005

By James Etheridge

MAT Biotech, Servier Agree To Monoclonal Antibody Deal

Feb. 2, 2005

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...